Autonomix Medical, Inc. Common Stock vs. Boston Scientific Corp.
Boston Scientific Corp. (BSX) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| AMIX | BSX | |
|---|---|---|
| Market Cap | $4.09 million | $63.11 billion |
| Revenue (TTM) | — | $21.00 billion |
| Net Income (TTM) | $-16,105,000 | $3.67 billion |
BSX leads on 3 of 3 size & scale factors.
Valuation
| AMIX | BSX | |
|---|---|---|
| P/E Ratio | — | 17.55 |
| Price / Book | 1.29 | 2.51 |
| Price / Sales | — | 3.01 |
AMIX leads on 1 of 1 valuation factors.
Profitability
| AMIX | BSX | |
|---|---|---|
| Net Margin | — | 17.47% |
| Return on Equity | -509.33% | 14.58% |
BSX leads on 1 of 1 profitability factors.
Risk & Sentiment
| AMIX | BSX | |
|---|---|---|
| Short Interest | 0.80% | 0.72% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMIX overview, AMIX financials, BSX overview, BSX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.